ICS 2014 Scientific Podium Poster Session S42 - Overview of Benign Prostatic Obstruction

Speakers
	Thursday 23rd October 2014
	14:30 - 16:00
	Room 1
A Ammar Alhasso ICS Chair J Jorge Antonio Pastro Noronha Local Chair

15:00

#651 A prospective randomized comparative study between the effect of Tamsulosin 0.4 mg and 0.2 mg on LUTS due to benign prostatic hyperplasia

Presenter: Ahmed Eissa

Eissa A¹, Gameel T¹, Adel Omar M¹, El-Bahnasy A H¹, Abdel Raheem A¹
1. Tanta University Hospital
Benign Prostatic Hyperplasia (BPH), Male, Quality of Life (QoL)

15:05

#652 Impact of morphometric analysis of prostate zonal anatomy on lower urinary tract symptom: Cooperative analysis of MRI-prostate in USA and Japan

Presenter: Toru Matsugasumi

Matsugasumi T¹, Ukimura O², Nakamoto M³, Ushijima S⁴, Kanazawa M⁴, Toiyama D⁴, Yamada Y⁴, Fujihara A⁴, Iwata T⁴, Miki T⁴, Palmer S³, Gill I³
1. Kyoto Prefectural University of Medicine, University of Southern California, 2. University of Southern California, Kyoto Prefectural University of Medicine, 3. University of Southern California, 4. Kyoto Prefectural University of Medicine
Anatomy, Benign Prostatic Hyperplasia (BPH), Bladder Outlet Obstruction , Imaging

15:10

#653 Location of the desire to void and urinary urgency in male patients with lower urinary tract symptoms

Presenter: Hironobu Akino

Akino H¹, Yokokawa R¹, Matsuta Y¹, Ito H¹, Oyama N¹, Nojiri M², Yokoyama O¹
1. Department of Urology, University of Fukui, 2. Hayashi Hospital
Male, Urgency/Frequency, Overactive Bladder

15:15

#654 Comparison of the efficacy and safety of tolterodine SR 2mg and 4mg combined with doxazosin in benign prostatic hyperplasia with overactive bladder symptoms : a prospective, randomized controlled trial

Presenter: Tae Heon Kim

Jung W¹, Kim T H², Jeong J³, Seo S I², Jeon S S², Lee H M², Choi H Y², Lee K²
1. Dongsan Medical Center, Keimyung University School of Medicine, 2. Samsung Medical Center, Sungkyunkwan University School of Medicine, 3. Center for Health Promotion, Samsung Medical Center, Sungkyunkwan University School of Medicine
Benign Prostatic Hyperplasia (BPH), Overactive Bladder, Clinical Trial

15:25

#655 A randomized controlled study to evaluate the efficacy of tamsulosin monotherapy and its combination with mirabegron on patients with overactive bladder induced by benign prostatic hyperplasia

Presenter: Naoya Masumori

Masumori N¹, Ichihara K¹, Fukuta F¹, Tsukamoto T¹, Iwasawa A², Tanaka Y³
1. Sapporo Medical University, 2. Iwasawa Clinic, 3. Esashi Prefectural Hospital
Benign Prostatic Hyperplasia (BPH), Male, Overactive Bladder

15:30

#656 The Results of Retropubic Prostatectomy, Transurethral Resection of Prostate and holmium laser enucleation; Compare Results, and then Investigate the Cause of Different Results

Presenter: Ji-Yeon Han

Han J¹, Kim S J², Lee S D¹
1. Pusan National University Yangsan Hospital, 2. Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine
Benign Prostatic Hyperplasia (BPH), Bladder Outlet Obstruction , Surgery

15:35

#657 Change in storage symptoms following laser prostatectomy: Comparison between potassium-titanyl-phosphate photoselective vaporization of the prostate (PVP) and holmium laser enucleation of the prostate (HoLEP)

Presenter: Min Chul Cho

Cho M C¹, Baik S², You K H³, Kim J K⁴, Ha S B⁴, Oh S⁴, Kim S W⁴, Paick J⁴
1. Dongguk University College of Medicine, 2. Chosun University Hospital, 3. Gwangmyeong Seongae Hospital, 4. Seoul National University College of Medicine
Benign Prostatic Hyperplasia (BPH), Urgency/Frequency, Overactive Bladder, Surgery

15:40

#658 The relationship between testosterone secretion and the improvement of bladder outlet obstruction by alpha1-blocker in men with benign prostatic hyperplasia

Presenter: Yoshihisa Matsukawa

Matsukawa Y¹, Takai S¹, Mori A¹, Funahashi Y¹, Yamamoto T¹, Gotoh M¹
1. Department of Urology, Nagoya University Graduate School of Medicine, Japan
Bladder Outlet Obstruction , Benign Prostatic Hyperplasia (BPH), Clinical Trial, Sexual Dysfunction , Male

15:45

#659 Intravesical prostatic protrusion (IPP), not prostate volume predicts outcomes of HoLEP in patients with lower urinary symptoms: implication for the mechanism of the bladder outlet obstruction.

Presenter: Hiroshi Kiuchi

Kiuchi H¹, Soda T¹, Takezawa K¹, Okuda H¹, Takao T¹, Miyagawa Y¹, Tsujimura A¹, Nonomura N¹
1. Osaka University
Benign Prostatic Hyperplasia (BPH), Surgery, Bladder Outlet Obstruction , Male, Voiding Dysfunction

15:50

#660 Efficacy and safety of tadalafil 5 mg once daily in Asian males with lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH-LUTS): Integrated analysis from 3 Asian double-blind, randomized, placebo-controlled clinical studies

Presenter: Masayuki Takeda

Takeda M¹, Murakami M², Morisaki Y³, Viktrup L⁴
1. 1. Department of Urology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Chuo, Japan, 2. 2. Lilly Research Laboratories Japan, Medical Science, Eli Lilly Japan K.K., Kobe, Japan, 3. 3. Lilly Research Laboratories Japan, Statistical Science, Eli Lilly Japan K.K., Kobe, Japan, 4. 4. Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana, USA
Benign Prostatic Hyperplasia (BPH), Bladder Outlet Obstruction , Clinical Trial, Male, Voiding Dysfunction

Content Visitors (staff only)

Overview of Benign Prostatic Obstruction

Scientific Podium Poster Session S42

Session Schedule

Comments

Chat